Arkolith/Insider Trading/VINC/Form 4

Izumi Raquel E.

See Remarks, DirectorVincerx Pharma, Inc. (VINC) · full profile →Form 4 · filed Jun 29, 2022
Net Buying
Open-Market Buys
$56K
Open-Market Sells
$0
Net Open-Market Flow
$56K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 27, 2022Buy(P)40K$1.41$56K40K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-22-024507) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML